TP53 and urinary bladder cancer: In subnetwork 2, tumour protein P53 (TP53) that was downregulated is connected to acetylsalicylic acid, AZD, and 1-(9-ethyl-9H-carbazol-3-yl)-N-methylmethanamine drugs (Fig. 6B), which basically means that these drugs can be potentially used together with NDV to enhance the oncolytic activity of NDV against EJ28 bladder cancer cell lines and prevent the cells from acquiring persistent infection.